Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device Robotic Surgery Robotics

Exec Chat: Rapid Expansion For CMR Surgical As It Launches Robotic System In More Countries

  • Interviews

Executive Summary

Per Vegard Nerseth, CEO of private surgical robotics company CMR Surgical, spoke to Medtech Insight about the UK firm's plans to democratize robot-assisted surgery.

You may also be interested in...



Exec Chat: CMR Surgical Prepares For Intensifying Competition In RAS

In an interview with Medtech Insight, Per Vegard Nerserth, CEO of CMR Surgical, discusses how the company adapted to the pandemic, its future plans, and how the competition for market dominance is shaping up.

Market Intel: Expanding Applications And Improved Offerings To Drive Robotically Assisted Surgery Market

The global market for robotically assisted surgical devices will reach $11.5bn by 2025 as system improvements drive sales.

CMR Surgical Closes SoftBank-Led Funding Round Worth $600M

CMR Surgical has raised $600m to globally commercialize its Versius surgical robotics platform.

Table

View full table

Related Content

Medtech Insight
Medtech Insight
Medtech Insight

Topics

Related Companies

Tags:
Medical Device Robotic Surgery Robotics
Latest Headlines

Minute Insight: Medtronic May Sell Respiratory And Monitoring Units To Private Equity

Stakeholders Give FDA An Earful; Poor Communication, Recall Inefficiency, Patients At Risk

Global Medtech Guidance Tracker: September 2023

‘Build A Company To Be Bought, Not Sold,' 'Match The Asset To The Capital,' And Other Advice From VC Experts

See All
UsernamePublicRestriction

Register

MT143492

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By